Literature DB >> 29336611

Interventions to improve benzodiazepine tapering success in the elderly: a systematic review.

Carol Dou1, Johannes Rebane1, Stan Bardal1.   

Abstract

BACKGROUND: Long-term benzodiazepine use in the elderly population is a significant public health problem that leads to impaired cognitive functioning, medication dependence and increased risks for adverse drug reactions. The aim of this review was to examine randomized controlled trials (RCTs) on the efficacy of different methods for tapering and discontinuing benzodiazepines.
METHOD: We used four databases (Ovid, PubMed, Academic Search Complete, Web of Science) to retrieve randomized controlled trials published in peer-reviewed journals that explored different methods for tapering benzodiazepine use in a primarily geriatric population.
RESULTS: Eleven papers met the inclusion criteria. Methods to assist in benzodiazepine tapering included patient education, cognitive behavioural therapy (CBT), and pharmaceutical adjuvants (SSRIs, melatonin, progesterone). Patient education was consistently effective in increasing benzodiazepine discontinuation success while CBT had mixed but promising results. The use of medications to help improve tapering success was inconclusive.
CONCLUSIONS: Patient education is a successful, time- and cost-effective intervention that can significantly help with benzodiazepine discontinuation success. CBT may also be an effective approach. However, cost can be an issue since public healthcare coverage in Canada does not cover psychotherapy. More research is needed in looking at pharmaceutical adjuvants and their role in assisting with benzodiazepine discontinuation.

Entities:  

Keywords:  CBT; Elderly; SSRIs; benzodiazepine; cognitive behavioural therapy; discontinuation; melatonin; patient education; progesterone; review; senior; tapering

Year:  2018        PMID: 29336611     DOI: 10.1080/13607863.2017.1423030

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  2 in total

Review 1.  Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.

Authors:  Perrine Evrard; Catherine Pétein; Jean-Baptiste Beuscart; Anne Spinewine
Journal:  Implement Sci       Date:  2022-07-08       Impact factor: 7.960

2.  Intervention to reduce benzodiazepine prescriptions in primary care, study protocol of a hybrid type 1 cluster randomised controlled trial: the BENZORED study.

Authors:  Caterina Vicens; Alfonso Leiva; Ferran Bejarano; Ermengol Sempere; Raquel María Rodríguez-Rincón; Francisca Fiol; Marta Mengual; Asunción Ajenjo; Fernando Do Pazo; Catalina Mateu; Silvia Folch; Santiago Alegret; Jose Maria Coll; María Martín-Rabadán; Isabel Socias
Journal:  BMJ Open       Date:  2019-01-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.